Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study: Biomarker Research for Tamoxifen Pharmacogenetics Among Asian Breast Cancer Patients

NCT01181518 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT01181518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01181518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study: Biomarker Research for Tamoxifen Pharmacogenetics Among Asian Breast Cancer Patients
Lead sponsor
Inje University
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2010
Completion date
December 31, 2015
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

poisoning by, adverse effect of and underdosing of tamoxifen